254 related articles for article (PubMed ID: 28409725)
21. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
22. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
[TBL] [Abstract][Full Text] [Related]
23. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic alterations of the NF2 gene in sporadic vestibular schwannomas.
Lee JD; Kwon TJ; Kim UK; Lee WS
PLoS One; 2012; 7(1):e30418. PubMed ID: 22295085
[TBL] [Abstract][Full Text] [Related]
25. The molecular genetics of vestibular schwannoma.
Moffat DA; Irving RM
J Laryngol Otol; 1995 May; 109(5):381-4. PubMed ID: 7797991
[TBL] [Abstract][Full Text] [Related]
26. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
[TBL] [Abstract][Full Text] [Related]
28. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
[TBL] [Abstract][Full Text] [Related]
29. Updates on Tumor Biology in Vestibular Schwannoma.
Nourbakhsh A; Dinh CT
Otolaryngol Clin North Am; 2023 Jun; 56(3):421-434. PubMed ID: 37121611
[TBL] [Abstract][Full Text] [Related]
30. Linked-read Sequencing Analysis Reveals Tumor-specific Genome Variation Landscapes in Neurofibromatosis Type 2 (NF2) Patients.
Roberts DS; Maurya R; Takemon Y; Vitte J; Gong L; Zhao J; Wong CH; Slattery W; Peng KA; Lekovic G; Schwartz MS; Bulsara K; Ngan CY; Giovannini M; Wei CL
Otol Neurotol; 2019 Feb; 40(2):e150-e159. PubMed ID: 30624408
[TBL] [Abstract][Full Text] [Related]
31. Familial unilateral vestibular schwannoma is rarely caused by inherited variants in the NF2 gene.
Evans DG; Wallace AJ; Hartley C; Freeman SR; Lloyd SK; Thomas O; Axon P; Hammerbeck-Ward CL; Pathmanaban O; Rutherford SA; Kellett M; Laitt R; King AT; Bischetsrieder J; Blakeley J; Smith MJ
Laryngoscope; 2019 Apr; 129(4):967-973. PubMed ID: 30325044
[TBL] [Abstract][Full Text] [Related]
32. Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma.
Håvik AL; Bruland O; Miletic H; Poulsgaard L; Scheie D; Fugleholm K; Lund-Johansen M; Knappskog PM
Acta Neurochir (Wien); 2022 Feb; 164(2):343-352. PubMed ID: 34816314
[TBL] [Abstract][Full Text] [Related]
33. ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy.
Doherty JK; Ongkeko W; Crawley B; Andalibi A; Ryan AF
Otol Neurotol; 2008 Jan; 29(1):50-7. PubMed ID: 18199957
[TBL] [Abstract][Full Text] [Related]
34. Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas.
Koutsimpelas D; Ruerup G; Mann WJ; Brieger J
ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):33-7. PubMed ID: 22249120
[TBL] [Abstract][Full Text] [Related]
35. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
36. Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma.
Zhang Z; Wang Z; Sun L; Li X; Huang Q; Yang T; Wu H
Genet Med; 2014 Mar; 16(3):264-70. PubMed ID: 24030433
[TBL] [Abstract][Full Text] [Related]
37. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
Halum SL; Erbe CB; Friedland DR; Wackym PA
Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
[TBL] [Abstract][Full Text] [Related]
38. Malignant transformation in vestibular schwannoma: report of a single case, literature search, and debate.
Seferis C; Torrens M; Paraskevopoulou C; Psichidis G
J Neurosurg; 2014 Dec; 121 Suppl():160-6. PubMed ID: 25434949
[TBL] [Abstract][Full Text] [Related]
39. What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?
Evans DG; Ramsden RT; Shenton A; Gokhale C; Bowers N; Huson SM; Wallace AJ
J Neurosurg; 2008 Jan; 108(1):92-6. PubMed ID: 18173316
[TBL] [Abstract][Full Text] [Related]
40. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.
Warren C; James LA; Ramsden RT; Wallace A; Baser ME; Varley JM; Evans DG
J Med Genet; 2003 Nov; 40(11):802-6. PubMed ID: 14627667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
